Personalizing Medication Management with Pharmacogenetic Testing (PGT) and Urine Drug Testing (UDT) in Primary Care

Through the use of case studies, this program will demonstrate how UDT and PGT provide objective information that may help clinicians make more effective prescribing decisions that are personalized for each patient. Identifying safe and effective treatment options for patients is critical for clinicians utilizing pharmacotherapy to help manage numerous disease states in primary care. PGT and UDT paired with clinical expertise can provide critical information about medication and substance use and can help clinicians monitor and support decisions about medication therapy.

Objectives: Upon completion of this session participants will be able to:

  • Conceptualize how PGT provides information which may be valuable for personalized medication therapy
  • Differentiate the advantages and limitations of the different types of UDTs & interpret results in the context of a patient’s clinical presentation
  • Through clinical vignettes, integrate PGT and UDT to understand how they may provide more complete information about medication efficacy and adverse drug reactions


Kelly Olsen, Ph.D.

Kelly Olson is the Associate Director of Clinical Affairs at Millennium Health. She is an experienced researcher in molecular neuro-pharmacology, as well as in clinical biology in the areas of mental illness, sleep, adrenal fatigue, and addictions. Dr. Olson has authored/co-authored a number of peer-reviewed articles, book chapters, and presentations, and has lectured extensively internationally, nationally, and locally. Dr. Olson has spent the majority of the past 9 years in integrative medicine, helping to improve patient clinical outcomes. She received her Masters of Science in exercise physiology from the University of North Dakota, and her PhD in pharmacology & therapeutics from the University of Manitoba.

Register to view the webinar